Here's the live share price of Rekvina Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Rekvina Laboratories | 18.06 | 6.22 | 80.70 | 49.46 | 775.42 | 106.10 | 68.97 |
| Sun Pharmaceutical Industries | -1.93 | -4.69 | -9.86 | 3.08 | 5.73 | 15.51 | 15.77 |
| Divi's Laboratories | -5.74 | -1.74 | 25.67 | 46.19 | 37.67 | 35.15 | 10.94 |
| Torrent Pharmaceuticals | -2.46 | -5.28 | -7.59 | 10.54 | 30.54 | 33.95 | 24.03 |
| Zydus Lifesciences | -2.60 | 2.27 | -0.87 | 20.09 | 14.79 | 23.95 | 15.61 |
| Laurus Labs | -0.92 | 5.88 | 30.53 | 82.28 | 132.27 | 72.23 | 25.62 |
| Cipla | -1.25 | -3.54 | -8.74 | 7.03 | -15.47 | 4.08 | 7.57 |
| Dr. Reddy's Laboratories | 0.97 | 5.60 | -2.54 | -0.34 | -1.87 | 3.41 | 4.12 |
| Aurobindo Pharma | -1.49 | -0.30 | 6.90 | 20.68 | 47.75 | 22.22 | 17.96 |
| Mankind Pharma | -6.60 | 1.81 | -7.92 | 9.78 | -4.35 | 8.68 | 10.35 |
| Lupin | -2.61 | -4.89 | -20.84 | -16.43 | 0.89 | 17.72 | 15.62 |
| Glenmark Pharmaceuticals | -1.85 | -5.49 | -2.65 | -0.69 | 18.52 | 41.19 | 33.73 |
| Alkem Laboratories | -2.72 | 1.14 | -6.87 | -6.50 | -5.11 | 13.05 | 6.02 |
| Biocon | -2.57 | -7.81 | -19.68 | 0.23 | -0.14 | 11.39 | 0.20 |
| Abbott India | 0.23 | 0.01 | -4.99 | 0.68 | -13.14 | 5.19 | 3.95 |
| Gland Pharma | -3.46 | 5.64 | 22.35 | 73.29 | 58.59 | 24.55 | -4.24 |
| Ipca Laboratories | -1.27 | -1.02 | 4.05 | 30.11 | 46.78 | 25.72 | 9.60 |
| Anthem Biosciences | -4.40 | -10.01 | 13.06 | 16.30 | 9.79 | 5.11 | 3.03 |
| GlaxoSmithKline Pharmaceuticals | -3.51 | -9.71 | 3.14 | 5.60 | -8.04 | 18.18 | 11.39 |
| Ajanta Pharma | -6.35 | -4.66 | -2.09 | 15.75 | 39.73 | 23.97 | 17.77 |
Source: Dion Global
Over the last one year, Rekvina Laboratories has gained 775.42% compared to peers like Sun Pharmaceutical Industries (5.73%), Divi's Laboratories (37.67%), Torrent Pharmaceuticals (30.54%). From a 5 year perspective, Rekvina Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (15.77%) and Divi's Laboratories (10.94%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 52.86 | 53.37 |
| 10 | 50.98 | 52.44 |
| 20 | 53.18 | 51.75 |
| 50 | 45.66 | 47.53 |
| 100 | 40.91 | 42.1 |
| 200 | 31.74 | 33.95 |
Source: Dion Global
In the latest quarter, Rekvina Laboratories saw a rise in promoter holding to 77.00%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 23.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Oct 08, 2026, 01:03 AM IST IST | Rekvina Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 30, 2026, 12:52 AM IST IST | Rekvina Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 29, 2026, 11:22 PM IST IST | Rekvina Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Sep 24, 2026, 01:21 AM IST IST | Rekvina Laboratories - Announcement Under Reg. 30 Of SEBI (LODR) Regulation 2015 - Noting Of Resignation |
| Sep 24, 2026, 01:19 AM IST IST | Rekvina Laboratories - Announcement under Regulation 30 (LODR)-Change in Registered Office Address |
Source: Dion Global
Rekvina Laboratories Ltd. is a Public Limited Listed company incorporated on 01/11/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1988PLC011458 and registration number is 011458. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1.27 Cr. and Equity Capital is Rs. 3.01 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rekvina Laboratories is ₹61.98 as on Oct 14, 2026.
The Rekvina Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Rekvina Laboratories is ₹37.36 Cr as on Oct 14, 2026.
Today’s highest and lowest price of Rekvina Laboratories are ₹61.98 and ₹57.00.
The 52-week high/low is the highest and lowest price at which Rekvina Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Rekvina Laboratories is ₹61.98 and 52-week low of Rekvina Laboratories is ₹6.75 as on Oct 14, 2026.
The Rekvina Laboratories has shown returns of 5.0% over the past day, 6.22% for the past month, 80.7% over 3 months, 775.42% over 1 year, 106.1% across 3 years, and 68.97% over 5 years.
P/E ratio of and PB ratio of Rekvina Laboratories are -109.99 and -27.70 on Oct 14, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global